APA

Shah T. T., Peters M., Kanthabalan A., McCartan N., Fatola Y., van der Voort van Zyp J., van Vulpen M., Freeman A., Moore C. M., Arya M., Emberton M. & Ahmed H. U. (20170418). PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure. : Prostate cancer and prostatic diseases.

Chicago

Shah T T, Peters M, Kanthabalan A, McCartan N, Fatola Y, van der Voort van Zyp J, van Vulpen M, Freeman A, Moore C M, Arya M, Emberton M and Ahmed H U. 20170418. PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure. : Prostate cancer and prostatic diseases.

Harvard

Shah T. T., Peters M., Kanthabalan A., McCartan N., Fatola Y., van der Voort van Zyp J., van Vulpen M., Freeman A., Moore C. M., Arya M., Emberton M. and Ahmed H. U. (20170418). PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure. : Prostate cancer and prostatic diseases.

MLA

Shah T T, Peters M, Kanthabalan A, McCartan N, Fatola Y, van der Voort van Zyp J, van Vulpen M, Freeman A, Moore C M, Arya M, Emberton M and Ahmed H U. PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure. : Prostate cancer and prostatic diseases. 20170418.